Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care

Excess Cancer Mortality in Psychiatric Patients

(2017) Stephen Kisely et al.   CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

Impact of Drug Tolerability on the Selection of Antidepressant Treatment in Patients With Major Depressive Disorder

(2016) Lawrence D. Ginsberg   CNS SPECTRUMS

Premature Mortality From General Medical Illnesses Among Persons With Bipolar Disorder: A Review

(2015) Babak Roshanaei-Moghaddam et al.   PSYCHIATRIC SERVICES

Physical health care in persons with severe mental illness: a public health and ethical priority

(2015) MARIO MAJ   World Psychiatry

Metabolic syndrome in people with schizophrenia: a review

(2015) MARC DE HERT et al.   World Psychiatry

Use of Cancer-Screening Services Among Persons With Serious Mental Illness in Sacramento County

(2014) Glen L. Xiong et al.   PSYCHIATRIC SERVICES

Assessing the STIRR Model of Best Practices for Blood-Borne Infections of Clients With Severe Mental Illness

(2014) Stanley D. Rosenberg et al.   PSYCHIATRIC SERVICES

Metabolic Screening in Children Receiving Antipsychotic Drug Treatment

(2012) Elaine H. Morrato et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP)

(2010) S. H. L. Thomas et al.   ACTA PSYCHIATRICA SCANDINAVICA

The influence of antiviral therapy on psychiatric symptoms among patients with hepatitis C and schizophrenia

(2010) Marilyn Huckans et al.   ANTIVIRAL THERAPY

Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs

(2010) Elaine H. Morrato et al.   ARCHIVES OF GENERAL PSYCHIATRY

Treatment with antipsychotics and the risk of diabetes in clinical practice

(2010) Lars Vedel Kessing et al.   BRITISH JOURNAL OF PSYCHIATRY

Twenty-five year mortality of a community cohort with schizophrenia

(2010) Steve Brown et al.   BRITISH JOURNAL OF PSYCHIATRY

Metabolic Syndrome Associated with Schizophrenia and Atypical Antipsychotics

(2010) Mehrul Hasnain et al.   Current Diabetes Reports

Cardiovascular aspects of antipsychotics

(2010) Thomas J Raedler   CURRENT OPINION IN PSYCHIATRY

Neurodevelopmental effects of prenatal exposure to psychotropic medications

(2010) Salvatore Gentile   DEPRESSION AND ANXIETY

Disruption of the Dopamine D2 Receptor Impairs Insulin Secretion and Causes Glucose Intolerance

(2010) Isabel García-Tornadú et al.   ENDOCRINOLOGY

Hospital admissions due to physical disease in people with schizophrenia: a national population-based study

(2010) Carmen Bouza et al.   GENERAL HOSPITAL PSYCHIATRY

Weight Gain and Insulin Resistance in Children Treated With Valproate: The Influence of Time

(2010) Fabio Masuccio et al.   JOURNAL OF CHILD NEUROLOGY

Prevalence of Overweight and Obesity in Adolescents With Severe Mental Illness

(2010) Barbara L. Gracious et al.   JOURNAL OF CLINICAL PSYCHIATRY

When Essential Medications Provoke New Health Problems: The Metabolic Effects of Second-Generation Antipsychotics

(2010) Karen Stein   JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION

A Generalist's Guide to Treating Patients With Depression With an Emphasis on Using Side Effects to Tailor Antidepressant Therapy

(2010) J. Michael Bostwick   MAYO CLINIC PROCEEDINGS

Antipsychotics Associated with the Development of Type 2 Diabetes in Antipsychotic-Naïve Schizophrenia Patients

(2010) Jimmi Nielsen et al.   NEUROPSYCHOPHARMACOLOGY

Depression, fracture risk, and bone loss: a meta-analysis of cohort studies

(2010) Q. Wu et al.   OSTEOPOROSIS INTERNATIONAL

Association ofHTR2C, but notLEPorINSIG2, genes with antipsychotic-induced weight gain in a German sample

(2010) Carolin Opgen-Rhein et al.   PHARMACOGENOMICS

Potential mechanisms of atypical antipsychotic-induced metabolic derangement: Clues for understanding obesity and novel drug design

(2010) Roberto Coccurello et al.   PHARMACOLOGY & THERAPEUTICS

Antidepressant-Induced Sexual Dysfunction among Newer Antidepressants in a Naturalistic Setting

(2010) Kyoung-Uk Lee et al.   Psychiatry Investigation

Considering a frame of reference for physical activity research related to the cardiometabolic risk profile in schizophrenia

(2010) Davy Vancampfort et al.   PSYCHIATRY RESEARCH

A head-to-head comparison of sertindole and risperidone on metabolic parameters

(2010) Marc De Hert et al.   SCHIZOPHRENIA RESEARCH

Prevalence of diabetes and antipsychotic prescription patterns in patients with schizophrenia: A nationwide retrospective cohort study

(2010) Yasuyuki Okumura et al.   SCHIZOPHRENIA RESEARCH

BMI AND RS1455832 SNP OF THE ROBO1 GENE: ASSOCIATION ANALYSIS IN PATIENTS USING ANTIPSYCHOTICS

(2010) Jelle Vehof et al.   SCHIZOPHRENIA RESEARCH

Prevalence of cardiovascular risk factors and disease in people with schizophrenia: A population-based study

(2010) Lauren C. Bresee et al.   SCHIZOPHRENIA RESEARCH

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

(2009) S. M. Stahl et al.   ACTA PSYCHIATRICA SCANDINAVICA

Physical Activity, Body Mass Index, and Diabetes Risk in Men: A Prospective Study

(2009) Lydia C. Siegel et al.   AMERICAN JOURNAL OF MEDICINE

Obesity Among Those with Mental Disorders

(2009) David B. Allison et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Long-Term Use of Antidepressants for Depressive Disorders and the Risk of Diabetes Mellitus

(2009) Frank Andersohn et al.   AMERICAN JOURNAL OF PSYCHIATRY

Somatic Hospital Contacts, Invasive Cardiac Procedures, and Mortality From Heart Disease in Patients With Severe Mental Disorder

(2009) Thomas Munk Laursen et al.   ARCHIVES OF GENERAL PSYCHIATRY

Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons

(2009) John C. Woolcott   ARCHIVES OF INTERNAL MEDICINE

Selective Serotonin Reuptake Inhibitor Exposure In Utero and Pregnancy Outcomes

(2009) Najaaraq Lund et al.   ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE

Treatment of ischaemic heart disease and stroke in individuals with psychosis under universal healthcare

(2009) Stephen Kisely et al.   BRITISH JOURNAL OF PSYCHIATRY

Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies

(2009) Alex J. Mitchell et al.   BRITISH JOURNAL OF PSYCHIATRY

Cancer mortality in patients with schizophrenia

(2009) Eric Tran et al.   CANCER

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Depression and coronary heart disease: association and implications for treatment.

(2009) J. A Blumenthal   CLEVELAND CLINIC JOURNAL OF MEDICINE

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: A review

(2009) Marco Tuccori et al.   CLINICAL THERAPEUTICS

Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders

(2009) Mario Álvarez-Jiménez et al.   CNS DRUGS

Bipolar Disorder and the Metabolic Syndrome

(2009) Andrea Fagiolini et al.   CNS DRUGS

Cardiovascular Abnormalities in Patients with Major Depressive Disorder

(2009) Alex D.H. Brown et al.   CNS DRUGS

Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes

(2009) E. H. Morrato et al.   DIABETES CARE

Obesity, serious mental illness and antipsychotic drugs

(2009) Richard I. G. Holt et al.   DIABETES OBESITY & METABOLISM

Does physical activity modify the risk of obesity for type 2 diabetes: a review of epidemiological data

(2009) Li Qin et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins

(2009) F.C.J. Starrenburg et al.   EUROPEAN PSYCHIATRY

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

(2009) M. De Hert et al.   EUROPEAN PSYCHIATRY

Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders

(2009) Kenneth Freedman et al.   Expert Review of Anti-Infective Therapy

Valproate-Induced Insulin Resistance and Obesity in Children

(2009) Alberto Verrotti et al.   HORMONE RESEARCH

Iloperidone for schizophrenia: a review of the efficacy and safety profile for this newly commercialised second-generation antipsychotic

(2009) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents

(2009) Christoph U. Correll   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)

(2009) Brian L. Storm et al.   JOURNAL OF CLINICAL PSYCHIATRY

Prevalence of Baseline Serum Glucose and Lipid Testing in Users of Second-Generation Antipsychotic Drugs

(2009) Elaine H. Morrato et al.   JOURNAL OF CLINICAL PSYCHIATRY

Life-Threatening Clozapine-Induced Gastrointestinal Hypomotility

(2009) Susanna E. Palmer et al.   JOURNAL OF CLINICAL PSYCHIATRY

Obesity in Patients With Severe Mental Illness

(2009) Susan L. McElroy   JOURNAL OF CLINICAL PSYCHIATRY

The Effects of Undertreated Chronic Medical Illnesses in Patients With Severe Mental Disorders

(2009) Andrea Fagiolini et al.   JOURNAL OF CLINICAL PSYCHIATRY

Comparing the Safety and Efficacy of Atypical Antipsychotics in Psychiatric Patients With Comorbid Medical Illnesses

(2009) John W. Newcomer   JOURNAL OF CLINICAL PSYCHIATRY

Second-Generation Antipsychotic–Associated Diabetes Mellitus and Diabetic Ketoacidosis: Mechanisms, Predictors, and Screening Need

(2009) Dan Cohen et al.   JOURNAL OF CLINICAL PSYCHIATRY

Fracture Risk From Psychotropic Medications

(2009) James M. Bolton et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Metabolic Risk Status and Second-Generation Antipsychotic Drug Selection

(2009) Elaine H. Morrato et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Systematic Overview of Cochrane Reviews for Anticholinergic Effects of Antipsychotic Drugs

(2009) Mehmet Ozbilen et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Polymorphisms of the LEP- and LEPR Gene and Obesity in Patients Using Antipsychotic Medication

(2009) Jochem G. Gregoor et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With Schizophrenia

(2009) Hans Mulder et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Sexual Dysfunction, Depression, and the Impact of Antidepressants

(2009) Sidney H. Kennedy et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Monitoring oral health and dental attendance in an outpatient psychiatric population

(2009) K. PERSSON et al.   Journal of Psychiatric and Mental Health Nursing

Use and Safety of Antipsychotic Drugs During Pregnancy

(2009) Adrienne Einarson et al.   Journal of Psychiatric Practice

The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness

(2009) RIG Holt et al.   JOURNAL OF PSYCHOPHARMACOLOGY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET

Metabolic Syndrome and Cancer

(2009) Pooja Pothiwala et al.   Metabolic Syndrome and Related Disorders

Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death

(2009) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Weight, Dietary Behavior, and Physical Activity in Childhood and Adolescence: Implications for Adult Cancer Risk

(2009) Bernard F. Fuemmeler et al.   Obesity Facts

Depression and low bone mineral density: a meta-analysis of epidemiologic studies

(2009) Q. Wu et al.   OSTEOPOROSIS INTERNATIONAL

The incidence of diabetes in atypical antipsychotic users differs according to agent-results from a multisite epidemiologic study

(2009) Marianne Ulcickas Yood et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness

(2009) Pamela Vergara-Rodriguez et al.   PHARMACOLOGY & THERAPEUTICS

Metabolic side effects of antipsychotic drug treatment – pharmacological mechanisms

(2009) Gavin P Reynolds et al.   PHARMACOLOGY & THERAPEUTICS

Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone

(2009) Marion van Bruggen et al.   PSYCHONEUROENDOCRINOLOGY

Are cervical cancer screening rates different for women with schizophrenia? A Manitoba population-based study

(2009) Patricia J. Martens et al.   SCHIZOPHRENIA RESEARCH

Does a diagnosis of schizophrenia reduce rates of mammography screening? A Manitoba population-based study

(2009) Harvey Max Chochinov et al.   SCHIZOPHRENIA RESEARCH

Weight effects associated with antipsychotics: A comprehensive database analysis

(2009) Bruce Parsons et al.   SCHIZOPHRENIA RESEARCH

Sexual problems in schizophrenia: prevalence and characteristics. A cross sectional survey

(2009) Ellen Wan-Yuk Harley et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

Consenso Español de Salud Física del Paciente con Trastorno Bipolar

(2009) Julio Bobes et al.   Revista de Psiquiatria y Salud Mental

Weight gain in bipolar disorder: pharmacological treatment as a contributing factor

(2008) C. Torrent et al.   ACTA PSYCHIATRICA SCANDINAVICA

Cancer incidence in patients with schizophrenia and their first-degree relatives – a meta-analysis

(2008) V. S. Catts et al.   ACTA PSYCHIATRICA SCANDINAVICA

Schizophrenia and physical health problems

(2008) Y. von Hausswolff-Juhlin et al.   ACTA PSYCHIATRICA SCANDINAVICA

The metabolic syndrome and schizophrenia

(2008) J. M. Meyer et al.   ACTA PSYCHIATRICA SCANDINAVICA

Psychotropic Drug Considerations in Depressed Patients with Metabolic Disturbances

(2008) W. Victor R. Vieweg et al.   AMERICAN JOURNAL OF MEDICINE

Depression and Ischemic Heart Disease Mortality: Evidence From the EPIC-Norfolk United Kingdom Prospective Cohort Study

(2008) Paul G. Surtees et al.   AMERICAN JOURNAL OF PSYCHIATRY

Mental Disorders, Quality of Care, and Outcomes Among Older Patients Hospitalized With Heart Failure

(2008) Saif S. Rathore et al.   ARCHIVES OF GENERAL PSYCHIATRY

Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders

(2008) Annette M Matthews et al.   BIPOLAR DISORDERS

Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder

(2008) Ruud van Winkel et al.   BIPOLAR DISORDERS

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics

(2008) Christoph U Correll et al.   BIPOLAR DISORDERS

The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)

(2008) Linda Hanssens et al.   BMC Psychiatry

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis

(2008) M. Smith et al.   BRITISH JOURNAL OF PSYCHIATRY

P.3.c.071 Epidemiological study for the evaluation of metabolic disorders in patients with schizophrenia: The METEOR Study

(2008) M. De Hert et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Association between obesity and depression in middle-aged women

(2008) Gregory E. Simon et al.   GENERAL HOSPITAL PSYCHIATRY

Sexual dysfunction in schizophrenia: focus on recent evidence

(2008) Martin Baggaley   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

The impact of mental illness on cardiac outcomes: A review for the cardiologist

(2008) Gillian L. Sowden et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease

(2008) Mary A. Whooley   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence and correlates of overweight in drug-naïve patients with bipolar disorder

(2008) Giuseppe Maina et al.   JOURNAL OF AFFECTIVE DISORDERS

Cardiovascular risk in patients with bipolar disorder

(2008) Maria P. Garcia-Portilla et al.   JOURNAL OF AFFECTIVE DISORDERS

HIV prevention for people with serious mental illness: a survey of mental health workers’ attitudes, knowledge and practice

(2008) Elizabeth Hughes et al.   JOURNAL OF CLINICAL NURSING

Quality of Care for Cardiovascular Disease-related Conditions in Patients with and without Mental Disorders

(2008) Amy M. Kilbourne et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Understanding osteoporosis

(2008) M Kassim Javaid et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia

(2008) Veronica O'Keane   JOURNAL OF PSYCHOPHARMACOLOGY

Adverse effects of prolactin in rodents and humans: breast and prostate cancer

(2008) Philip W. Harvey et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample

(2008) Amber A. Mather et al.   JOURNAL OF PSYCHOSOMATIC RESEARCH

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

(2008) René S Kahn et al.   LANCET

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

(2008) Stefan Leucht et al.   LANCET

Diabetic Ketoacidosis Associated with Aripiprazole

(2008) Zaineb H Makhzoumi et al.   PHARMACOTHERAPY

Schizophrenia, Obesity, and Antipsychotic Medications: What Can We Do?

(2008) Leslie Citrome et al.   POSTGRADUATE MEDICINE

High bone turnover but normal bone mineral density in women suffering from schizophrenia

(2008) N. Bergemann et al.   PSYCHOLOGICAL MEDICINE

HIV testing among individuals with a severe mental illness: review, suggestions for research, and clinical implications

(2008) T. E. Senn et al.   PSYCHOLOGICAL MEDICINE

Body composition in psychotic disorders: a general population survey

(2008) S. E. Saarni et al.   PSYCHOLOGICAL MEDICINE

Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin?

(2008) Henderikus Knegtering et al.   PSYCHONEUROENDOCRINOLOGY

Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia

(2008) Beata Konarzewska et al.   PSYCHONEUROENDOCRINOLOGY

Overweight and Obesity Are Associated With Psychiatric Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

(2008) Nancy M. Petry et al.   PSYCHOSOMATIC MEDICINE

Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review

(2008) Marc De Hert et al.   SCHIZOPHRENIA RESEARCH

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

(2008) Gail L. Daumit et al.   SCHIZOPHRENIA RESEARCH

A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: Findings from the CLAMORS study

(2008) Celso Arango et al.   SCHIZOPHRENIA RESEARCH

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH

An increased risk of stroke among young schizophrenia patients

(2008) Herng-Ching Lin et al.   SCHIZOPHRENIA RESEARCH

Medical comorbidity in patients with schizophrenia and alcohol dependence

(2008) Steven L. Batki et al.   SCHIZOPHRENIA RESEARCH

Type of antidepressant therapy and risk of type 2 diabetes in people with depression

(2007) Lauren C. Brown et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome

(2007) Rie Oka et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The prevalence of metabolic syndrome in patients with bipolar disorder

(2007) Maria P. Garcia-Portilla et al.   JOURNAL OF AFFECTIVE DISORDERS

Obesity and mental disorders in the adult general population

(2007) Kate M. Scott et al.   JOURNAL OF PSYCHOSOMATIC RESEARCH

Concordance of standard and modified NCEP ATP III criteria for identification of metabolic syndrome in outpatients with schizophrenia treated with antipsychotics: A corollary from the CLAMORS study

(2007) Javier Rejas et al.   SCHIZOPHRENIA RESEARCH

Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950–2005

(2007) Rebecca M. Capasso et al.   SCHIZOPHRENIA RESEARCH